跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
URSOFALK CAPSULE 250 MG - HSA Drug Approval Details
Approvals
/
HSA
/
URSOFALK CAPSULE 250 MG
Approved
THERAPEUTIC
URSOFALK CAPSULE 250 MG
LOSAN PHARMA GMBH - GERMANYLOSAN PHARMA GMBH (PRIMARY & SECONDARY PACKAGER) (GERMANY)
🇸🇬 Health Sciences Authority
Approval Date
Apr 8, 1991
Approval ID
c2cf99a2f889b762
Company
LOSAN PHARMA GMBH - GERMANYLOSAN PHARMA GMBH (PRIMARY & SECONDARY PACKAGER) (GERMANY)
Type
Therapeutic
Approval Details
Approval Id
c2cf99a2f889b762
Drug Name
URSOFALK CAPSULE 250 MG
Product Name
URSOFALK CAPSULE 250 MG
Approval Number
SIN05742P
Approval Date
1991-04-08
Registrant
DCH AURIGA SINGAPORE
Licence Holder
DCH AURIGA SINGAPORE
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
Pending
Atc Item Name
xpending
Pharma Manufacturer Name
DCH AURIGA SINGAPORE
Active Ingredients
URSODEOXYCHOLIC ACID
250 mg
URSODEOXYCHOLIC ACID
250 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 8, 1991
Approval ID
c2cf99a2f889b762
Type
Therapeutic
Back to HSA Approvals